APA (7th ed.) Citation

Suzuki, S., Otani, T., Ikeda, K., Tamura, N., & Morimoto, S. Additional benefits of belimumab in chronic phase of systemic lupus erythematosus and efficacy of tacrolimus combination therapy. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Suzuki, Satoshi, Tomoya Otani, Keigo Ikeda, Naoto Tamura, and Shinji Morimoto. Additional Benefits of Belimumab in Chronic Phase of Systemic Lupus Erythematosus and Efficacy of Tacrolimus Combination Therapy. Taylor & Francis Group.

MLA (9th ed.) Citation

Suzuki, Satoshi, et al. Additional Benefits of Belimumab in Chronic Phase of Systemic Lupus Erythematosus and Efficacy of Tacrolimus Combination Therapy. Taylor & Francis Group.

Warning: These citations may not always be 100% accurate.